Johnson & Johnson buys Innovasive to build share in sports medicine
This article was originally published in Clinica
Johnson & Johnson is to boost its position in the sports medicine and arthroscopy markets through the acquisition of Innovasive Devices for $85 million. Innovasive will become a wholly owned subsidiary of J&J and will operate as part of J&J's Ethicon division. Under the deal, Innovasive shareholders will receive $8.25 in J&J shares for each share held in Innovasive.